Point72 Middle East FZE’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-38,300
Closed -$3.16M 813
2023
Q4
$3.16M Buy
38,300
+14,200
+59% +$1.08M 0.09% 285
2023
Q3
$1.89M Buy
24,100
+8,000
+50% +$670K 0.06% 371
2023
Q2
$1.42M Buy
16,100
+2,900
+22% +$250K 0.04% 479
2023
Q1
$1.06M Sell
13,200
-600
-4% -$48.9K 0.04% 483
2022
Q4
$1.07M Buy
+13,800
New +$1.12M 0.05% 485

Other funds holding MDT

Point72 Middle East FZE's MDT Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Medtronic (MDT) in Q1 2024, closing a stake of 21,764 shares — an estimated $1.79M sold.

Point72 Middle East FZE first reported a position in MDT in Q4 2022 and held it in 3 quarters. The position peaked at $13.9M in Q1 2023. 2,076 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 21,764 Medtronic shares in Q1 2024, an estimated $1.79M.
  • Point72 Middle East FZE first reported a position in Medtronic in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's Medtronic position peaked at $13.9M in Q1 2023.
  • 2,076 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.